Infinity Market Research
Infinity Market Research

Global 5?-Reductase Inhibitors Market Growth 2025-2031


Oct 2025

Healthcare

Pages: 170

LPI17799

PDF Available
Word Available
Excel Available


The global 5?-Reductase Inhibitors market size is predicted to grow from US$ 895 million in 2025 to US$ 1293 million in 2031; it is expected to grow at a CAGR of 6.3% from 2025 to 2031.


5?-Reductase inhibitors are a class of medications that block the action of the enzyme 5?-reductase, which converts testosterone into dihydrotestosterone (DHT), a more potent androgen. By reducing DHT levels, these inhibitors can help treat conditions such as benign prostatic hyperplasia (BPH) and androgenetic alopecia (male pattern baldness). Common examples include finasteride and dutasteride.


United States market for 5?-Reductase Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.


China market for 5?-Reductase Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.


Europe market for 5?-Reductase Inhibitors is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.


Global key 5?-Reductase Inhibitors players cover Organon, GSK, Waylis Therapeutics, Dr. Reddys Laboratories, Teva, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.


Infinity Market Research newest research report, the 5?-Reductase Inhibitors Industry Forecast looks at past sales and reviews total world 5?-Reductase Inhibitors sales in 2024, providing a comprehensive analysis by region and market sector of projected 5?-Reductase Inhibitors sales for 2025 through 2031. With 5?-Reductase Inhibitors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 5?-Reductase Inhibitors industry.


This Insight Report provides a comprehensive analysis of the global 5?-Reductase Inhibitors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 5?-Reductase Inhibitors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global 5?-Reductase Inhibitors market.


This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 5?-Reductase Inhibitors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 5?-Reductase Inhibitors.


This report presents a comprehensive overview, market shares, and growth opportunities of 5?-Reductase Inhibitors market by product type, application, key manufacturers and key regions and countries.


Segmentation by Type:


    Dutasteride
    Finasteride


Segmentation by Application:


    Male Pattern Baldness
    Benign Prostatic Hyperplasia (BPH)
    Other


This report also splits the market by region:


    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries


The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.


    Organon
    GSK
    Waylis Therapeutics
    Dr. Reddys Laboratories
    Teva
    Aurobindo Pharma
    Zydus
    Hetero
    Accord Healthcare
    Sun Pharma
    Alkem
    Amneal Pharmaceuticals
    Strides Pharma
    Chartwell
    Humanwell Pharmaceutical
    Grand Pharmaceutical
    CR Double-Crane
    Zhejiang Conba Pharmaceutical
    Topfond Pharmaceutical
    Zhejiang Xianju Pharmaceutical
    Shanghai Shyndec Pharmaceutical
    Humanwell Puracap
    Sichuan Gowell Pharmaceutical
    Chengdu Suncadia Medicine
    Qilu Pharmaceutical
    Jiangsu Wangao Pharmaceutical


Key Questions Addressed in this Report


What is the 10-year outlook for the global 5?-Reductase Inhibitors market?
What factors are driving 5?-Reductase Inhibitors market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 5?-Reductase Inhibitors market opportunities vary by end market size?
How does 5?-Reductase Inhibitors break out by Type, by Application?


📘 Frequently Asked Questions

1. What is the market size of Global 5?-Reductase Inhibitors Market?

Answer: The Global 5?-Reductase Inhibitors Market size was estimated at USD 895 million in 2025 to US$ 1293 in 2024 and is expected to reach USD XX million in 2034.

2. Which regions are analyzed in the Global 5?-Reductase Inhibitors Market report?

Answer: The Global 5?-Reductase Inhibitors Market report covers major regions such as Europe, Middle East & Africa. Each region is analyzed for trends, opportunities, and market dynamics.

3. What methodology is used for forecasting of Global 5?-Reductase Inhibitors Market?

Answer: The Global 5?-Reductase Inhibitors Market report uses a mix of primary research, secondary data, and expert analysis to build its forecasts. Models include both qualitative and quantitative approaches.

4. Are emerging markets analyzed separately in the Global 5?-Reductase Inhibitors Market?

Answer: Yes, the Global 5?-Reductase Inhibitors Market report highlights high-growth emerging regions with dedicated insights. These include untapped opportunities, risks, and potential for expansion.

5. Does the report include competitive benchmarking of Global 5?-Reductase Inhibitors Market?

Answer: Yes, Global 5?-Reductase Inhibitors Market report compares major players based on revenue, product portfolio, innovation, and regional presence. This helps assess competitive positioning.

6. Can I access country-level data within the Global 5?-Reductase Inhibitors Market report?

Answer: Yes, Global 5?-Reductase Inhibitors Market report includes detailed data by country, especially for key markets. This allows for localized insights and decision-making.

7. Can I get customized insights or data from the Global 5?-Reductase Inhibitors Market report?

Answer: Yes, we offer customization options to align with your specific business needs. You can request tailored sections or regional breakdowns.

🎁 This Month Only: Flat $1000 OFF

Enjoy an exclusive $1000 discount on every report purchased this month. No code needed.

Secure payment methods

🔐 Secure Payment Guaranteed

Safe checkout with trusted global payment methods.

🌟 Why Choose Infinity Market Research?

  • Accurate & Verified Data:Our insights are trusted by global brands and Fortune 500 companies.
  • Complete Transparency:No hidden fees, locked content, or misleading claims — ever.
  • 24/7 Analyst Support:Our expert team is always available to help you make smarter decisions.
  • Instant Savings:Enjoy a flat $1000 OFF on every report.
  • Fast & Reliable Delivery:Get your report delivered within 5 working days, guaranteed.
  • Tailored Insights:Customized research that fits your industry and specific goals.

📄 Available License Types

👤 Single User
$3660
$2660
👥 Multi User
$5490
$4490
🏢 Enterprise User
$7320
$6320
Buy Now
Secure payment methods

Recent Reports

Cancer Treatment Support Services Market

The global Cancer Treatment Support Services market projected to hit US$ 1204 million in 2025 to US$ 1813 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.

Generative AI Data Center Market

The global Generative AI Data Center market projected to hit US$ 7255 million in 2025 to US$ 20170 million in 2031; it is expected to grow at a CAGR of 18.6% from 2025 to 2031.